Merck shared safety and efficacy results of MK-1084; either as monotherapy or in combinations, it demonstrated a manageable safety profile.

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

(SMMT) stock rises as its lung cancer drug ivonescimab with chemotherapy hit the main goal in a Phase 3 trial for lung cancer ...

Shares of ORIC Pharmaceuticals ORIC surged more than 20% in the pre-market hours today after announcing potentially ...

Merck’s MRK shares have lost 21.3% so far this year compared with a decrease of 4.5% for the industry. The stock has also ...

There are two main types of lung cancer: non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Several subtypes exist within these categories, and there are a few other ...

Breast cancer is the second leading cause of cancer death in women. (Only lung cancer kills more women each year.) The chance that any woman will die from breast cancer is about 1 in 43 (about 2.3%).

One company to watch right now is Hang Lung Properties (HLPPY). HLPPY is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 9.50.

Objectives To examine the accuracy and impact of artificial intelligence (AI) software assistance in lung cancer screening using CT. Methods A systematic review of CE-marked, AI-based software for ...

“I’m a glass half full. I am positive and optimistic and if we’re fighting, I’m going to be the healthiest lung cancer patient they’ve ever had,” Duhamel encouragingly said.

SANTA MONICA, Calif. — A California man battling lung cancer is unable to get treatment he planned for after being denied by his health insurance company Cigna Healthcare. Daron Wells ...

Deron Wells is battling stage 4 lung cancer. The husband and father of three is also now battling his insurance company. "I am really sad that my life is in the hands of these decision-makers who ...